Progress and analysis on the development of 2019-nCoV vaccine.
10.7507/1001-5515.202004025
- Author:
Zhuang KANG
1
,
2
;
Mei TANG
3
Author Information
1. College of Life Science, Leshan Normal University, Leshan, Sichuan 614000, P.R.China
2. Department of Biotechnology, Chengdu Institute of Biological Products, Chengdu 610000, P.R.China.
3. College of Life Science, Leshan Normal University, Leshan, Sichuan 614000, P.R.China.
- Publication Type:Journal Article
- Keywords:
2019-nCoV;
attenuated live vaccine;
inactivated vaccine;
nucleic acid vaccine;
recombinant protein vaccine
- MeSH:
Betacoronavirus;
Coronavirus Infections;
prevention & control;
Humans;
Pandemics;
prevention & control;
Pneumonia, Viral;
prevention & control;
Viral Vaccines;
therapeutic use
- From:
Journal of Biomedical Engineering
2020;37(3):373-379
- CountryChina
- Language:Chinese
-
Abstract:
As the COVID-19 pandemic is intensifying globally, more and more people are pinning their hopes on the development of vaccines. At present, there are many research teams who have adopted different vaccine technology routes to develop 2019-nCoV vaccines. This article reviews and analyzes the current development and research status of 2019-nCoV vaccines in different routes, and explores their possible development in the future.
